IRIS - Res&Arch Institutional Research Information System - Research & Archive

TIACCI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.791
EU - Europa 2.336
AS - Asia 2.019
SA - Sud America 337
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 7.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.724
SG - Singapore 960
IT - Italia 720
IE - Irlanda 413
BR - Brasile 300
CN - Cina 293
HK - Hong Kong 292
UA - Ucraina 239
RU - Federazione Russa 226
VN - Vietnam 214
DE - Germania 157
FI - Finlandia 146
SE - Svezia 144
KR - Corea 99
GB - Regno Unito 65
NL - Olanda 47
FR - Francia 43
CA - Canada 32
IN - India 30
TR - Turchia 28
MX - Messico 27
PL - Polonia 27
AT - Austria 23
BD - Bangladesh 22
BE - Belgio 22
JP - Giappone 19
CZ - Repubblica Ceca 18
AR - Argentina 17
CH - Svizzera 14
ES - Italia 13
EC - Ecuador 9
IQ - Iraq 9
UZ - Uzbekistan 8
ZA - Sudafrica 8
LB - Libano 6
MA - Marocco 5
BG - Bulgaria 4
GR - Grecia 4
ID - Indonesia 4
KZ - Kazakistan 4
OM - Oman 4
PE - Perù 4
CI - Costa d'Avorio 3
CO - Colombia 3
IR - Iran 3
KG - Kirghizistan 3
LT - Lituania 3
PK - Pakistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
KE - Kenya 2
LK - Sri Lanka 2
NE - Niger 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CL - Cile 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MZ - Mozambico 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TN - Tunisia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 7.519
Salva come PNG Salva come JPEG
Città #
Singapore 614
Dublin 413
Chandler 410
Perugia 337
Hong Kong 292
San Mateo 218
Ashburn 162
Boardman 154
Dong Ket 132
Santa Clara 131
Jacksonville 109
Seoul 99
Altamura 95
Medford 91
Princeton 89
Moscow 85
Ann Arbor 77
Lawrence 73
Beijing 72
Munich 64
Wilmington 63
Andover 60
New York 57
Dallas 53
Helsinki 46
Des Moines 42
Rome 39
Amsterdam 38
São Paulo 36
Turku 36
Los Angeles 34
The Dalles 33
Ho Chi Minh City 30
Piscataway 28
Saint Petersburg 25
Izmir 23
Brussels 22
Redmond 22
Nuremberg 21
Houston 20
Norwalk 19
Hanoi 17
Tokyo 17
Woodbridge 17
Montreal 16
Brooklyn 14
Frankfurt am Main 14
London 13
Mexico City 12
San Francisco 12
San Paolo di Civitate 12
Warsaw 12
Belo Horizonte 11
Stockholm 11
Chicago 10
Poplar 10
Redwood City 10
Terni 10
Orem 9
Phoenix 9
Atlanta 8
Boston 8
Brno 8
Chennai 8
Johannesburg 8
Porto Alegre 8
Rio de Janeiro 8
Shanghai 8
Todi 8
Manchester 7
Olomouc 7
Falkenstein 6
Falls Church 6
Guayaquil 6
Haiphong 6
Hefei 6
Recife 6
Changsha 5
Columbus 5
Curitiba 5
Dhaka 5
Foligno 5
Guangzhou 5
Seattle 5
Toronto 5
Vienna 5
Brasília 4
Charlotte 4
Denver 4
Duncan 4
Lappeenranta 4
Lausanne 4
Mumbai 4
Muscat 4
Paris 4
Querétaro 4
San Jose 4
Tashkent 4
Trieste 4
Verona 4
Totale 4.923
Salva come PNG Salva come JPEG
Nome #
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 152
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 141
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 122
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 116
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 115
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 111
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 109
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 105
A microRNA signature specific for hairy cell leukemia and associated with modulation of the MAPK-JNK pathways. 103
Genomics of Hairy cell leukemia 101
Improved achiral and chiral hplc-uv analysis of ruxolitinib in two different drug formulations 101
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 96
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 95
Choroidal vasculature analysis in MEK inhibitor-associated retinopathy 94
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 93
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 93
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia. 93
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 93
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 93
BRAF mutations in hairy-cell leukemia. 92
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial 92
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 91
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 90
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 86
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 85
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 85
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 85
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor 84
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 84
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 83
Aspects of gene expression in B cell lymphomas 83
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin 83
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 82
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 82
Mutational landscape of AML with normal cytogenetics: biological and clinical implications 81
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 81
ALK signaling and target therapy in anaplastic large cell lymphoma 81
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia 80
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 80
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia 80
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression 80
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 80
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 79
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 77
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 77
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 77
Hairy Cell Leukemia Biomarkers and Methods of Using Same 75
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. 74
BRAF V600E mutation in hairy cell leukemia: From bench to bedside 74
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 73
Primary Burkitt's lymphoma of bladder in patient with AIDS. 72
Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors 71
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors 70
How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors 70
Overlapping features of therapy-related and de novoNPM1-mutated AML 69
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) 68
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications 67
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 66
New treatment options in hairy cell leukemia with focus on BRAF inhibitors 66
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. 66
New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues. 64
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. 63
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemia. 63
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 62
PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia 62
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. 62
The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis. 62
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia 61
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 60
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation 60
The genetics of nodal marginal zone lymphoma 60
T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. 59
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 59
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia. 57
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma. 57
The authors reply 57
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas [Tiacci and Lazzi are co-senior authors] 57
Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma. 56
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 56
The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma 56
[Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma] 54
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia 53
One disease, two faces: clonally-related AML and MPDCP with skin involvement 51
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. 51
Lymphoma 51
Anaplastic large-cell lymphoma 51
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 49
Starry sky pattern predicts RAS pathway activation in NPM1‐mutated acute myeloid leukemia 47
Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma. [Tiacci, Mecucci and Kueppers are co-senior authors] 47
Transformation of IGHV4-34+ hairy cell leukaemia-variant with U2AF1 mutation into a clonally-related high grade B-cell lymphoma responding to immunochemotherapy 47
Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia 46
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. 46
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement 45
SAVI: a statistical algorithm for variant frequency identification. 45
An unusual form of BRAF‐V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine 44
Hairy cell leukaemia mimicking multiple myeloma 43
Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. 42
Gene dosage effects in chronic lymphocytic leukemia. 41
Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells 38
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall 37
Totale 7.368
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021422 0 0 0 0 0 36 33 43 102 22 48 138
2021/2022925 16 155 4 21 24 8 12 233 59 71 197 125
2022/20231.412 97 268 17 115 101 146 4 49 522 37 43 13
2023/2024604 35 41 43 13 8 9 140 3 51 19 125 117
2024/20251.734 64 173 60 72 235 90 108 123 322 101 249 137
2025/20261.766 277 207 155 363 654 110 0 0 0 0 0 0
Totale 7.872